Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 20 | 2022 | 686 | 4.330 |
Why?
|
| Heart Defects, Congenital | 26 | 2022 | 1866 | 3.480 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2021 | 373 | 3.240 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2024 | 1176 | 2.330 |
Why?
|
| Pediatrics | 12 | 2022 | 1213 | 2.230 |
Why?
|
| Hemodynamics | 14 | 2023 | 855 | 2.060 |
Why?
|
| Critical Illness | 11 | 2023 | 618 | 2.050 |
Why?
|
| Monitoring, Physiologic | 11 | 2022 | 380 | 1.720 |
Why?
|
| Oxygen | 8 | 2021 | 572 | 1.600 |
Why?
|
| Intensive Care Units, Pediatric | 9 | 2021 | 466 | 1.490 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 178 | 1.470 |
Why?
|
| Cardiology | 4 | 2017 | 498 | 1.450 |
Why?
|
| Oximetry | 7 | 2021 | 178 | 1.330 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2021 | 153 | 1.300 |
Why?
|
| Heart Failure | 8 | 2016 | 2393 | 1.280 |
Why?
|
| Capnography | 2 | 2020 | 13 | 1.210 |
Why?
|
| Cardiovascular System | 2 | 2023 | 107 | 1.210 |
Why?
|
| Heart Diseases | 4 | 2019 | 513 | 1.160 |
Why?
|
| Sepsis | 2 | 2023 | 515 | 1.140 |
Why?
|
| Child | 46 | 2022 | 25789 | 0.960 |
Why?
|
| Nitric Oxide | 5 | 2019 | 471 | 0.960 |
Why?
|
| Cardiac Output | 7 | 2022 | 167 | 0.890 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2017 | 343 | 0.890 |
Why?
|
| Physicians | 3 | 2022 | 643 | 0.850 |
Why?
|
| Humans | 84 | 2024 | 132062 | 0.840 |
Why?
|
| Arginine Vasopressin | 1 | 2023 | 28 | 0.820 |
Why?
|
| Heart | 4 | 2023 | 700 | 0.810 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2014 | 655 | 0.760 |
Why?
|
| Blood Pressure | 6 | 2022 | 1400 | 0.750 |
Why?
|
| Hypertension, Pulmonary | 5 | 2019 | 460 | 0.730 |
Why?
|
| Certification | 2 | 2019 | 72 | 0.720 |
Why?
|
| Cerebrovascular Circulation | 3 | 2021 | 476 | 0.720 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 158 | 0.710 |
Why?
|
| Tetralogy of Fallot | 3 | 2012 | 176 | 0.710 |
Why?
|
| Fontan Procedure | 1 | 2023 | 186 | 0.700 |
Why?
|
| Lung | 2 | 2020 | 1559 | 0.700 |
Why?
|
| Postoperative Complications | 8 | 2020 | 3142 | 0.690 |
Why?
|
| Inflammation | 2 | 2020 | 1517 | 0.690 |
Why?
|
| Heart-Assist Devices | 3 | 2022 | 1081 | 0.670 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 28 | 0.660 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 672 | 0.650 |
Why?
|
| Infant, Newborn | 17 | 2022 | 8549 | 0.640 |
Why?
|
| Infant | 24 | 2020 | 13064 | 0.610 |
Why?
|
| Triiodothyronine | 1 | 2019 | 59 | 0.600 |
Why?
|
| Internationality | 1 | 2019 | 133 | 0.590 |
Why?
|
| Hypothyroidism | 1 | 2019 | 78 | 0.570 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 340 | 0.570 |
Why?
|
| Postoperative Care | 5 | 2020 | 312 | 0.570 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 558 | 0.570 |
Why?
|
| Respiratory Tract Diseases | 2 | 2016 | 80 | 0.560 |
Why?
|
| Curriculum | 2 | 2022 | 772 | 0.550 |
Why?
|
| Hospital Mortality | 5 | 2021 | 1057 | 0.540 |
Why?
|
| Vasopressins | 3 | 2021 | 45 | 0.520 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 3091 | 0.520 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 278 | 0.510 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 211 | 0.500 |
Why?
|
| Immunomodulation | 1 | 2016 | 78 | 0.490 |
Why?
|
| Respiratory System | 1 | 2016 | 98 | 0.480 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 110 | 0.470 |
Why?
|
| Shock | 1 | 2016 | 98 | 0.460 |
Why?
|
| Immune System Diseases | 1 | 2015 | 52 | 0.460 |
Why?
|
| Societies, Medical | 5 | 2015 | 778 | 0.460 |
Why?
|
| Clinical Competence | 2 | 2019 | 1067 | 0.450 |
Why?
|
| Child, Preschool | 18 | 2020 | 14751 | 0.450 |
Why?
|
| Congresses as Topic | 1 | 2015 | 185 | 0.430 |
Why?
|
| Child Abuse | 1 | 2017 | 204 | 0.430 |
Why?
|
| Education, Medical | 1 | 2017 | 304 | 0.410 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 44 | 0.410 |
Why?
|
| Shock, Septic | 1 | 2015 | 154 | 0.410 |
Why?
|
| Ventilator Weaning | 2 | 2010 | 28 | 0.410 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 324 | 0.400 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 305 | 0.390 |
Why?
|
| Cardiovascular Diseases | 3 | 2016 | 2092 | 0.390 |
Why?
|
| Vascular Resistance | 2 | 2020 | 196 | 0.390 |
Why?
|
| Vancomycin | 1 | 2014 | 222 | 0.380 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 212 | 0.370 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 16 | 0.360 |
Why?
|
| Airway Extubation | 1 | 2012 | 70 | 0.360 |
Why?
|
| Length of Stay | 6 | 2021 | 1379 | 0.350 |
Why?
|
| Cardiac Output, Low | 1 | 2010 | 62 | 0.330 |
Why?
|
| Positive-Pressure Respiration | 1 | 2010 | 85 | 0.330 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 133 | 0.320 |
Why?
|
| Intensive Care Units | 6 | 2020 | 523 | 0.320 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 44 | 0.320 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 68 | 0.310 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 31 | 0.310 |
Why?
|
| Brain | 2 | 2012 | 3183 | 0.310 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 78 | 0.300 |
Why?
|
| Treatment Outcome | 12 | 2024 | 13028 | 0.300 |
Why?
|
| Retrospective Studies | 15 | 2022 | 17419 | 0.300 |
Why?
|
| Coronary Care Units | 4 | 2020 | 33 | 0.300 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 662 | 0.290 |
Why?
|
| Diuretics | 3 | 2019 | 160 | 0.280 |
Why?
|
| Postoperative Period | 4 | 2019 | 335 | 0.280 |
Why?
|
| Respiration, Artificial | 6 | 2019 | 504 | 0.280 |
Why?
|
| Steroids | 1 | 2009 | 173 | 0.280 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 547 | 0.270 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 137 | 0.270 |
Why?
|
| Arteries | 2 | 2019 | 222 | 0.260 |
Why?
|
| Fluid Therapy | 2 | 2022 | 147 | 0.250 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2021 | 129 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 1247 | 0.250 |
Why?
|
| Hospitalization | 5 | 2021 | 1898 | 0.250 |
Why?
|
| Dexamethasone | 3 | 2005 | 276 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2024 | 305 | 0.230 |
Why?
|
| Administration, Inhalation | 3 | 2019 | 190 | 0.230 |
Why?
|
| Respiration | 3 | 2016 | 124 | 0.230 |
Why?
|
| Prospective Studies | 7 | 2020 | 6567 | 0.230 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2009 | 332 | 0.230 |
Why?
|
| Male | 22 | 2020 | 64922 | 0.210 |
Why?
|
| Creatinine | 2 | 2017 | 412 | 0.210 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2016 | 56 | 0.210 |
Why?
|
| Acute Disease | 3 | 2016 | 1160 | 0.210 |
Why?
|
| Heart Rate | 3 | 2020 | 591 | 0.210 |
Why?
|
| Mediastinum | 1 | 2023 | 48 | 0.200 |
Why?
|
| Cause of Death | 2 | 2019 | 510 | 0.200 |
Why?
|
| Female | 22 | 2020 | 70712 | 0.200 |
Why?
|
| Time Factors | 6 | 2019 | 6448 | 0.200 |
Why?
|
| Hemodynamic Monitoring | 1 | 2022 | 16 | 0.190 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 230 | 0.190 |
Why?
|
| Water | 1 | 2023 | 195 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2558 | 0.190 |
Why?
|
| Vena Cava, Superior | 1 | 2021 | 59 | 0.170 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 272 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3418 | 0.170 |
Why?
|
| Biological Transport | 2 | 2011 | 349 | 0.170 |
Why?
|
| Tidal Volume | 1 | 2020 | 41 | 0.160 |
Why?
|
| Nicardipine | 1 | 2020 | 17 | 0.160 |
Why?
|
| Age Factors | 2 | 2019 | 2912 | 0.160 |
Why?
|
| United States | 6 | 2022 | 11658 | 0.160 |
Why?
|
| Nitroprusside | 1 | 2020 | 37 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2020 | 56 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 141 | 0.160 |
Why?
|
| Hypotension | 1 | 2021 | 185 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 518 | 0.160 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 44 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2021 | 3736 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 32 | 0.150 |
Why?
|
| Acidosis | 1 | 2020 | 101 | 0.150 |
Why?
|
| Arginine | 1 | 2021 | 343 | 0.150 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 150 | 0.140 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 245 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 182 | 0.140 |
Why?
|
| Oliguria | 1 | 2017 | 20 | 0.130 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 82 | 0.130 |
Why?
|
| Nurses | 1 | 2017 | 73 | 0.130 |
Why?
|
| Chlorothiazide | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nephrons | 1 | 2016 | 17 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 461 | 0.130 |
Why?
|
| Diuresis | 1 | 2016 | 46 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1672 | 0.130 |
Why?
|
| Veins | 1 | 2017 | 104 | 0.130 |
Why?
|
| Adolescent | 6 | 2021 | 20562 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 853 | 0.120 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 10 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2016 | 38 | 0.120 |
Why?
|
| Alprostadil | 1 | 2015 | 22 | 0.120 |
Why?
|
| Specialization | 1 | 2016 | 80 | 0.120 |
Why?
|
| Risk Factors | 4 | 2020 | 10941 | 0.120 |
Why?
|
| Inpatients | 1 | 2020 | 551 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 749 | 0.120 |
Why?
|
| Weight Gain | 1 | 2017 | 381 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2019 | 1573 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2017 | 330 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 137 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2019 | 791 | 0.110 |
Why?
|
| Premedication | 2 | 2005 | 42 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 207 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1436 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 243 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5409 | 0.110 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 136 | 0.110 |
Why?
|
| Publications | 1 | 2013 | 35 | 0.100 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 552 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 588 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1170 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2020 | 1227 | 0.100 |
Why?
|
| Global Health | 1 | 2017 | 643 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 224 | 0.100 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2012 | 5 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 207 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 215 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 1838 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2016 | 571 | 0.090 |
Why?
|
| Animals | 4 | 2024 | 34882 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2016 | 408 | 0.090 |
Why?
|
| Texas | 3 | 2015 | 3629 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 189 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 123 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1234 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1396 | 0.090 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 276 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 3761 | 0.090 |
Why?
|
| Calcium | 1 | 2016 | 1078 | 0.080 |
Why?
|
| California | 1 | 2010 | 137 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 79 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1331 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 1572 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 88 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 777 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 27 | 0.080 |
Why?
|
| Reperfusion | 1 | 2009 | 26 | 0.080 |
Why?
|
| Pressure | 1 | 2009 | 131 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 82 | 0.070 |
Why?
|
| Biomarkers | 2 | 2014 | 3406 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 199 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 215 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 377 | 0.060 |
Why?
|
| Incidence | 1 | 2014 | 3380 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2391 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2005 | 98 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 713 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1301 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1408 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2024 | 33 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 1358 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 386 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 26 | 0.050 |
Why?
|
| Troponin I | 1 | 2003 | 126 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 16 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 23 | 0.050 |
Why?
|
| Morbidity | 2 | 2015 | 256 | 0.050 |
Why?
|
| Prognosis | 1 | 2011 | 5009 | 0.040 |
Why?
|
| Japan | 1 | 2020 | 157 | 0.040 |
Why?
|
| Complement C3a | 1 | 2000 | 19 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2003 | 1659 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 156 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 98 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 251 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 128 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 451 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 222 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 128 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2000 | 433 | 0.030 |
Why?
|
| Neutrophils | 1 | 2000 | 361 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 58 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 664 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 541 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 34 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 247 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2019 | 230 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 457 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 9 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 242 | 0.030 |
Why?
|
| Bradycardia | 1 | 2014 | 60 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 17 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7566 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1180 | 0.020 |
Why?
|
| Gases | 1 | 2012 | 20 | 0.020 |
Why?
|
| Missouri | 1 | 2012 | 42 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 257 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 241 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2014 | 183 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 31568 | 0.020 |
Why?
|
| Troponin | 1 | 2012 | 79 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 698 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 819 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 1694 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2014 | 425 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1470 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 993 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 609 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1450 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2224 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 293 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9957 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2005 | 211 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 435 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21406 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1009 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28964 | 0.010 |
Why?
|